236 related articles for article (PubMed ID: 27358136)
1. BLCA-4 and UBC combined detection for early diagnosis of bladder cancer.
Cui L; Sun MM; Zhao ZH; Yang JP; Zheng YP; He LL; Chen KS; Fan QX
J Biol Regul Homeost Agents; 2016; 30(2):485-90. PubMed ID: 27358136
[TBL] [Abstract][Full Text] [Related]
2. Clinical usefulness of the novel marker BLCA-4 for the detection of bladder cancer.
Konety BR; Nguyen TS; Brenes G; Sholder A; Lewis N; Bastacky S; Potter DM; Getzenberg RH
J Urol; 2000 Sep; 164(3 Pt 1):634-9. PubMed ID: 10953114
[TBL] [Abstract][Full Text] [Related]
3. [Clinical value of combined detection with urinary bladder cancer antigen, hyaluronic acid and cytokeratin 20 in diagnosis of bladder cancer].
Pu XY; Wang ZP; Chen YR; Wu YL; Wang HP; Wang XH
Ai Zheng; 2008 Sep; 27(9):970-3. PubMed ID: 18799038
[TBL] [Abstract][Full Text] [Related]
4. Urinary BLCA-4 is highly specific for detection of bladder cancer in Chinese Han population and is related to tumour invasiveness.
Feng CC; Wang PH; Guan M; Jiang HW; Wen H; Ding Q; Wu Z
Folia Biol (Praha); 2011; 57(6):242-7. PubMed ID: 22264718
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of cytology, nuclear matrix protein 22 (NMP22) test, and urinary bladder cancer II (UBC II) test in early recurrent transitional cell carcinoma of the bladder.
Kibar Y; Goktas S; Kilic S; Yaman H; Onguru O; Peker AF
Ann Clin Lab Sci; 2006; 36(1):31-8. PubMed ID: 16501234
[TBL] [Abstract][Full Text] [Related]
6. Urine BLCA-4 exerts potential role in detecting patients with bladder cancers: a pooled analysis of individual studies.
Cai Q; Wu Y; Guo Z; Gong R; Tang Y; Yang K; Li X; Guo X; Niu Y; Zhao Y
Oncotarget; 2015 Nov; 6(35):37500-10. PubMed ID: 26462026
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the monoclonal UBC-ELISA test and the NMP22 ELISA test for the detection of urothelial cell carcinoma of the bladder.
Mian C; Lodde M; Haitel A; Vigl EE; Marberger M; Pycha A
Urology; 2000 Feb; 55(2):223-6. PubMed ID: 10688083
[TBL] [Abstract][Full Text] [Related]
8. [Cytokeratins (UBC and CYFRA 21-1) and nuclear matrix proteins (NMP22) as urine tumor markers in the diagnosis of bladder cancer].
Sánchez-Carbayo M; Urrutia M; Hernández-Cerceño ML; González de Buitrago JM; Navajo JA
Med Clin (Barc); 2000 Mar; 114(10):361-6. PubMed ID: 10786344
[TBL] [Abstract][Full Text] [Related]
9. Highly specific urine-based marker of bladder cancer.
Van Le TS; Miller R; Barder T; Babjuk M; Potter DM; Getzenberg RH
Urology; 2005 Dec; 66(6):1256-60. PubMed ID: 16360453
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of Serological and Urological Levels of Bladder Cancer-Specific Antigen-1 (BLCA-1) in Bladder Cancer.
Wang Z; Li H; Chi Q; Qiu Y; Li X; Xin L
Med Sci Monit; 2018 Jun; 24():3882-3887. PubMed ID: 29883442
[TBL] [Abstract][Full Text] [Related]
11. Use of the novel marker BLCA-1 for the detection of bladder cancer.
Myers-Irvin JM; Landsittel D; Getzenberg RH
J Urol; 2005 Jul; 174(1):64-8. PubMed ID: 15947579
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a New Survivin ELISA and UBC
Gleichenhagen J; Arndt C; Casjens S; Meinig C; Gerullis H; Raiko I; Brüning T; Ecke T; Johnen G
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29324722
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
14. Bladder Cancer-Specific Nuclear Matrix Proteins-4 May Be a Potential Biomarker for Non-Muscle-Invasive Bladder Cancer Detection.
Wang ZY; Li HY; Wang H; Chi Q; Liu Y; Li XM
Dis Markers; 2018; 2018():5609395. PubMed ID: 30275913
[TBL] [Abstract][Full Text] [Related]
15. Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4.
Konety BR; Nguyen TS; Dhir R; Day RS; Becich MJ; Stadler WM; Getzenberg RH
Clin Cancer Res; 2000 Jul; 6(7):2618-25. PubMed ID: 10914702
[TBL] [Abstract][Full Text] [Related]
16. Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade recurrence.
Boman H; Hedelin H; Holmäng S
J Urol; 2002 Jan; 167(1):80-3. PubMed ID: 11743280
[TBL] [Abstract][Full Text] [Related]
17. UBC
Ecke TH; Weiß S; Stephan C; Hallmann S; Barski D; Otto T; Gerullis H
Tumour Biol; 2017 May; 39(5):1010428317701624. PubMed ID: 28468590
[TBL] [Abstract][Full Text] [Related]
18. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
[TBL] [Abstract][Full Text] [Related]
19. Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer.
Herman MP; Svatek RS; Lotan Y; Karakiewizc PI; Shariat SF
Minerva Urol Nefrol; 2008 Dec; 60(4):217-35. PubMed ID: 18923359
[TBL] [Abstract][Full Text] [Related]
20. Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls.
Güllü Amuran G; Tinay I; Filinte D; Ilgin C; Peker Eyüboğlu I; Akkiprik M
Int Urol Nephrol; 2020 Mar; 52(3):461-468. PubMed ID: 31679136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
